Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
467-02-003 ISMRM Abstract

Papillary muscle T2 mapping in acute myocardial infarction

Accepted
Théo Richard 1, Victor de Villedon de Naide1,2, Edouard Gerbaud1,3, Sane Viola1,2, Thaïs Génisson1,2, Kalvin Narceau1,2, Ewan Barel1,2, Pierre Jaïs1,4, Matthias Stuber1,5,6, Hubert Cochet1,2, Aurelien Bustin1,2,5
1IHU LIRYC, Heart Rhythm Disease Institute, Bordeaux, France
2Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, Bordeaux, France
3Cardiology Intensive Care Unit and Interventional Cardiology, Hôpital Cardiologique du Haut-Lévêque, Bordeaux, France
4Hôpital Cardiologique du Haut-Lévêque, Bordeaux, France
5Department of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland
6Center for Biomedical Imaging (CIBM), Lausanne, Switzerland
Presenting Author: Théo Richard

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Eitel I, Gehmlich D, Amer O, et al. Prognostic relevance of papillary muscle infarction in reperfused infarction as visualized by cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2013;6(6):890-898. doi:10.1161/CIRCIMAGING.113.000411 [doi]
2. Okayama S, Uemura S, Soeda T, et al. Clinical significance of papillary muscle late enhancement detected via cardiac magnetic resonance imaging in patients with single old myocardial infarction. Int J Cardiol. 2011;146(1):73-79. doi:10.1016/j.ijcard.2010.04.037 [doi]
3. Bouma W, Willemsen HM, Lexis CP, et al. Chronic ischemic mitral regurgitation and papillary muscle infarction detected by late gadolinium-enhanced cardiac magnetic resonance imaging in patients with ST-segment elevation myocardial infarction. Clin Res Cardiol. 2016;105(12):981-991. doi:10.1007/s00392-016-1006-9 [doi]
4. Bogun F, Desjardins B, Crawford T, et al. Post-infarction ventricular arrhythmias originating in papillary muscles. J Am Coll Cardiol. 2008;51(18):1794-1802. doi:10.1016/j.jacc.2008.01.046 [doi]
5. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1445-1453. doi:10.1056/NEJM200011163432003 [doi]
6. Van De Heyning CM, Holtackers RJ, Nazir MS, et al. Dark-blood late gadolinium enhancement CMR improves detection of papillary muscle fibrosis in patients with mitral valve prolapse. Eur J Radiol. 2022;147:110118. doi:10.1016/j.ejrad.2021.110118 [doi]
7. Ibanez B, Aletras AH, Arai AE, et al. Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;74(2):238-256. doi:10.1016/j.jacc.2019.05.024 [doi]
8. Richard T, de Villedon de Naide V, Nogues V, et al. Improved and Automated Detection of Papillary Muscle Infarction Using Joint Bright- and Black-Blood Late Gadolinium Enhancement MRI. J Magn Reson Imaging. 2025;62(3):827-839. doi:10.1002/jmri.29777 [doi]
9. Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19(1):75. Published 2017 Oct 9. doi:10.1186/s12968-017-0389-8 [doi]

Cite this abstract